Allogeneic Genetically Modified T Cells (HSV-TK) As Adjunctive Treatment in Haploidentical Hematopoietic Stem-Cell Transplantation (haplo-HSCT) of Adult Patients with High-Risk Hematological Malignancies: A Pair-Matched Analysis from the Acute Leukemia Working Party of EBMT

Transplantation, Ganciclovir, Medicine, Hematopoietic stem cell transplantation, Oncology, Stem cell, Immunology, Suicide gene, Internal medicine, Genetic enhancement, Biology, Human cytomegalovirus